Home       Privacy       Archive       Realtime Report



Stock Trading History of Huckel Hubert E Md

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Huckel Hubert E Md since year 2005. The trader's CIK number is 1121608. At the time of this reporting, Huckel Hubert E Md is the Director of Catalyst Pharmaceutical Partners, Inc. (stock ticker symbol CPRX).
Note that in the past HUCKEL HUBERT E MD also reported insider trading activities as an insider of the following companies:

Stock purchases, sales, and option exercises reported by insider Huckel Hubert E Md since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2008-02-07 CPRX Catalyst Pharmaceutical Partners, Inc. Purchase 14,200 3.45 48,990
2008-01-30 CPRX Catalyst Pharmaceutical Partners, Inc. Purchase 10,800 3.05 32,940
2007-11-16 KOOL Thermogenesis Corp Purchase 146,000 1.97 287,620
2007-07-20 KOOL Thermogenesis Corp Option Exercise 10,000 1.81 18,100
2007-02-26 VLRX Valera Pharmaceuticals Inc Option Exercise 25,208 3.00 75,624
2007-02-26 VLRX Valera Pharmaceuticals Inc Sale 25,208 8.30 209,262
2007-01-30 KOOL Thermogenesis Corp Option Exercise 4,000 2.34 9,360
2006-05-12 KOOL Thermogenesis Corp Purchase 50,000 4.02 200,749
2006-02-02 VLRX Valera Pharmaceuticals Inc Purchase 3,300 9.00 29,700
2005-10-24 TTP Titan Pharmaceuticals Inc Purchase 25,700 1.72 44,229

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Huckel Hubert E Md (Director of Catalyst Pharmaceutical Partners, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.